1. Home
  2. CMPX vs NEXA Comparison

CMPX vs NEXA Comparison

Compare CMPX & NEXA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPX
  • NEXA
  • Stock Information
  • Founded
  • CMPX 2014
  • NEXA 1956
  • Country
  • CMPX United States
  • NEXA Luxembourg
  • Employees
  • CMPX N/A
  • NEXA N/A
  • Industry
  • CMPX Biotechnology: Pharmaceutical Preparations
  • NEXA Metal Mining
  • Sector
  • CMPX Health Care
  • NEXA Basic Materials
  • Exchange
  • CMPX Nasdaq
  • NEXA Nasdaq
  • Market Cap
  • CMPX 576.5M
  • NEXA 646.3M
  • IPO Year
  • CMPX N/A
  • NEXA 2017
  • Fundamental
  • Price
  • CMPX $3.65
  • NEXA $5.10
  • Analyst Decision
  • CMPX Strong Buy
  • NEXA Sell
  • Analyst Count
  • CMPX 7
  • NEXA 4
  • Target Price
  • CMPX $14.71
  • NEXA $5.25
  • AVG Volume (30 Days)
  • CMPX 1.7M
  • NEXA 64.2K
  • Earning Date
  • CMPX 11-11-2025
  • NEXA 10-30-2025
  • Dividend Yield
  • CMPX N/A
  • NEXA 1.98%
  • EPS Growth
  • CMPX N/A
  • NEXA N/A
  • EPS
  • CMPX N/A
  • NEXA N/A
  • Revenue
  • CMPX N/A
  • NEXA $2,785,931,000.00
  • Revenue This Year
  • CMPX N/A
  • NEXA N/A
  • Revenue Next Year
  • CMPX N/A
  • NEXA $3.34
  • P/E Ratio
  • CMPX N/A
  • NEXA N/A
  • Revenue Growth
  • CMPX N/A
  • NEXA 7.34
  • 52 Week Low
  • CMPX $1.27
  • NEXA $4.44
  • 52 Week High
  • CMPX $4.08
  • NEXA $9.61
  • Technical
  • Relative Strength Index (RSI)
  • CMPX 56.88
  • NEXA 58.57
  • Support Level
  • CMPX $3.31
  • NEXA $4.91
  • Resistance Level
  • CMPX $3.80
  • NEXA $5.10
  • Average True Range (ATR)
  • CMPX 0.24
  • NEXA 0.23
  • MACD
  • CMPX -0.01
  • NEXA 0.01
  • Stochastic Oscillator
  • CMPX 70.51
  • NEXA 37.73

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

About NEXA Nexa Resources S.A.

Nexa Resources SA is a low-cost integrated zinc producer. It produces copper, silver, and gold as byproducts. The company operates through two segments namely Mining and Smelting. Its Mining segment consists of various operating units includes mineral exploration activities and the production of zinc concentrates, copper concentrates and concentrates. The Smelting segment comprises operating units which include facilities recovering and refining zinc metal out of feed materials such as zinc concentrates or secondary feed materials. It generates maximum revenue from the Smelting segment. Geographically It has a presence in Brazil, Peru, the United States of America, Switzerland, Japan, Argentina, South Korea, Colombia, Vietnam, Malaysia and other countries.

Share on Social Networks: